Literature DB >> 8694583

Interleukin-6 in clinical relapses of polymyalgia rheumatica and giant cell arteritis.

D Caplanne, J M Le Parc, J A Alexandre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8694583      PMCID： PMC1010195          DOI： 10.1136/ard.55.6.403-b

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  8 in total

1.  The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis.

Authors:  G G Hunder; D A Bloch; B A Michel; M B Stevens; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie
Journal:  Arthritis Rheum       Date:  1990-08

Review 2.  Stopping steroids in polymyalgia rheumatica and giant cell arteritis.

Authors:  V Kyle; B L Hazelman
Journal:  BMJ       Date:  1990-02-10

3.  Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up.

Authors:  V Kyle; T E Cawston; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1989-08       Impact factor: 19.103

4.  Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis.

Authors:  B Dasgupta; G S Panayi
Journal:  Br J Rheumatol       Date:  1990-12

5.  Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis.

Authors:  N E Roche; J W Fulbright; A D Wagner; G G Hunder; J J Goronzy; C M Weyand
Journal:  Arthritis Rheum       Date:  1993-09

6.  The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome.

Authors:  M E Ellis; S Ralston
Journal:  Ann Rheum Dis       Date:  1983-04       Impact factor: 19.103

7.  Serum C-reactive protein in polymyalgia rheumatica. A prospective serial study.

Authors:  R K Mallya; C R Hind; H Berry; M B Pepys
Journal:  Arthritis Rheum       Date:  1985-04

8.  An evaluation of criteria for polymyalgia rheumatica.

Authors:  H A Bird; W Esselinckx; A S Dixon; A G Mowat; P H Wood
Journal:  Ann Rheum Dis       Date:  1979-10       Impact factor: 19.103
  8 in total
  2 in total

Review 1.  Gaps in Aging Research as it Applies to Rheumatologic Clinical Care.

Authors:  Una E Makris; Devyani Misra; Raymond Yung
Journal:  Clin Geriatr Med       Date:  2016-10-18       Impact factor: 3.076

Review 2.  Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy.

Authors:  Shunsuke Mori; Yukinori Koga
Journal:  Clin Rheumatol       Date:  2014-05-08       Impact factor: 2.980
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.